New share issue in Pharma Way AB

Pharma Way AB carries out a new share issue of SEK 15 million. The new capital will be used to finance the launch of Dot Shot in USA and Europe through e-commerce. During 2020, the Company has established a wholly owned subsidiary in the United States, Pharma Way North America LLC, and made all preparations for the launch of Dot Shot in the United States during May 2021. 

DOT SHOT is a well-documented wellness shot based on water-soluble curcumin from turmeric with faster and better effect which provides an increased value for the consumer compared to current products in the Europe and US market. 

The US wellness shot market is valued at over USD 450 million and increase by 15-20% annually. The market is expected to continue its strong growth as US consumers look for products that help them improve their overall health and well-being. The market has also benefit from the current Corona pandemic and is expected to continue strong growth in the coming years. 

For more information about the new share issue contact Mårten Österlund either by mail marten.osterlund@pharma-way.com or by phone +46706916767


Older Post Newer Post